General Discussion
Related: Editorials & Other Articles, Issue Forums, Alliance Forums, Region ForumsF.D.A. Blocked Publication of Research Finding Covid and Shingles Vaccines Were Safe
Officials at the Food and Drug Administration have blocked publication of several studies supporting the safety of widely used vaccines against Covid-19 and shingles in recent months, a spokesman for the Department of Health and Human Services confirmed.
The studies, which cost millions of dollars in public funds, were conducted by scientists at the agency, who worked with data firms to analyze millions of patient records. They found serious side effects to be very rare.
In October, the scientists were directed to withdraw two Covid-19 vaccine studies that had been accepted for publication in medical journals. In February, top F.D.A. officials did not sign off on submitting abstracts about studies of Shingrix, a shingles vaccine, to a major drug safety conference.
The withdrawal of the studies is the latest step by the administration to try to limit access to vaccines. It has sharply cut research funding for vaccine development, released unvetted information casting doubt on vaccines, and blocked other information supporting their safety, most recently a paper on Covid vaccine effectiveness by career scientists from the Centers for Disease Control and Prevention.
https://www.nytimes.com/2026/05/05/us/politics/fda-covid-vaccine-studies.html?
*************************************************************************************
Actively trying to kill us.
erronis
(24,383 posts)Shingles is a horrible virus and can sometimes have long term consequences. And guess what? Just as the mRNA technology they are so anxious to kill is showing vast promise for curing cancer, the shingles vaccine is looking more and more like a preventative for dementia:
A new study suggests that the vaccine for shingles may also be protective against dementia--findings that Harvard T.H. Chan School of Public Health's Alberto Ascherio calls "promising."
Ascherio, professor of epidemiology and nutrition, was among the experts quoted in a Dec. 2 Washington Post article about the study, which was led by researchers at Stanford University. (Ascherio was not involved.) Leveraging a natural experiment in Wales, researchers compared the cognitive outcomes of two groups of older adults--one that received the shingles vaccine, and another that didn't because they missed the eligibility cutoff. The study found that, among the vaccinated, those who remained cognitively healthy were less likely to develop mild cognitive impairment, and those who did develop dementia were nearly 30% less likely to die from it over the course of nine years.
The results "suggest that there is a slowing of this degenerative process," Ascherio told the Post. More research is needed to confirm the findings--but the study is a particularly strong one, Ascherio and others pointed out, because of its randomized controlled nature.
But sure, let's keep the information from the American people because some crank with a brain worm and his addled followers read something on YouTube.